Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Arizona Health Center COVID-19 Survey Summary Report

Arizona Health Center COVID-19 Survey Summary Report

Latest data from June 17, 2022

Number of Health Center respondents = 19 (83% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 3,491
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 77.40%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 719
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 81.27%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 17.47% 14.74%
White, Hispanic/Latino Patients 32.91% 35.74%
Black/African American, Non-Hispanic/Latino Patients 3.01% 2.09%
Black/African American, Hispanic/Latino Patients 0.26% 0.28%
Asian Patients3 0.83% 0.83%
American Indian/Alaska Native Patients3 5.44% 7.37%
Native Hawaiian/Other Pacific Islander Patients3 0.20% 0.42%
Patients with More Than One Race3 7.59% 6.82%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 9.60% 10.43%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.38% 1.81%
Unreported/Refused to Report Race and Ethnicity 18.30% 19.47%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 730
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 84.96%
COVID-19 Immunization Series Completed 437
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 83.83%
COVID-19 Immunization Series Additional 2,149
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 74.76%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 13.29% 12.36% 20.43%
White, Hispanic/Latino Patients 49.18% 40.05% 39.13%
Black/African American, Non-Hispanic/Latino Patients 8.49% 4.12% 2.56%
Black/African American, Hispanic/Latino Patients 0.55% 0.69% 0.28%
Asian Patients3 1.92% 0.69% 0.56%
American Indian/Alaska Native Patients3 2.05% 2.06% 1.02%
Native Hawaiian/Other Pacific Islander Patients3 0.14% 0.23% 0.09%
Patients with More Than One Race3 1.10% 5.72% 9.17%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 11.64% 10.53% 7.68%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.05% 9.61% 1.86%
Unreported/Refused to Report Race and Ethnicity 9.59% 13.96% 17.22%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 10.53%
1 to 24 Hours 42.11%
More Than 24 Hours 47.37%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 5.26%
Staffing to administer the vaccine 42.11%
Vaccine confidence 21.05%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 5.26%
None 36.84%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 15.79%
Average Percent of Health Center Visits Conducted Virtually 16.05%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 26.32%
Number of Mobile Van Sites 7
Number of Pop-up Clinics 6
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 12

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 42.11%
None 57.89%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 10.53%
Patient awareness/education 10.53%
Staffing capacity 26.32%
Therapy administration/onsite logistics 21.05%
Other 5.26%
None 42.11%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 15
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 4,514

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 93.33%
Provided to General Public Who Came to the Health Center 73.33%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 20.00%
Provided at Other Community Events 33.33%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 13.33%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 13.33%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 0.00%
Provided to school-age children and/or their families directly or through partnerships with schools 6.67%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 6.67%
Other 6.67%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 8
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 5,627

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 100.00%
Provided to General Public Who Came to the Health Center 62.50%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 25.00%
Provided at Other Community Events 37.50%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 25.00%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 25.00%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 0.00%
Provided to school-age children and/or their families directly or through partnerships with schools 0.00%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 0.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 5
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 56.07%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 18.22%
White, Hispanic/Latino Patients 35.98%
Black/African American, Non-Hispanic/Latino Patients 4.67%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 3.27%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.93%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 11.21%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.93%
Unreported/Refused to Report Race and Ethnicity 24.77%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 0.93%
Patients Experiencing Homelessness 0.47%
Patients Who Are Residents of Public Housing 3.27%
Patients with Limited English Proficiency 6.07%
Children Under 18 Years of Age 0.93%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: